| __timestamp | Ultragenyx Pharmaceutical Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10811000 | 17992000000 |
| Thursday, January 1, 2015 | 33001000 | 22400000000 |
| Friday, January 1, 2016 | 64936000 | 23910000000 |
| Sunday, January 1, 2017 | 99909000 | 23813000000 |
| Monday, January 1, 2018 | 127724000 | 24694000000 |
| Tuesday, January 1, 2019 | 161524000 | 23557000000 |
| Wednesday, January 1, 2020 | 182933000 | 25436000000 |
| Friday, January 1, 2021 | 219982000 | 24586000000 |
| Saturday, January 1, 2022 | 278139000 | 27295000000 |
| Sunday, January 1, 2023 | 309799000 | 34205000000 |
| Monday, January 1, 2024 | 28113000000 |
Unleashing insights
In the ever-evolving landscape of corporate finance, Selling, General, and Administrative (SG&A) expenses serve as a critical indicator of a company's operational efficiency. From 2014 to 2023, Walgreens Boots Alliance, Inc. and Ultragenyx Pharmaceutical Inc. have showcased contrasting trajectories in their SG&A expenditures. Walgreens, a retail giant, consistently reported SG&A costs exceeding $20 billion annually, reflecting its expansive global operations. In contrast, Ultragenyx, a biotech firm, saw its SG&A expenses grow nearly 30-fold, from approximately $10 million in 2014 to over $300 million in 2023, highlighting its rapid expansion and investment in innovation. Notably, Walgreens' expenses peaked in 2024, while Ultragenyx's data for that year remains unavailable. This comparison underscores the diverse strategies and growth patterns of established versus emerging companies in the healthcare sector.
Amgen Inc. and Ultragenyx Pharmaceutical Inc.: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Bio-Techne Corporation or Ultragenyx Pharmaceutical Inc.
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc.
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Halozyme Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or Geron Corporation
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs BioCryst Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Grifols, S.A. vs Ultragenyx Pharmaceutical Inc.
Cost Management Insights: SG&A Expenses for Ultragenyx Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Celldex Therapeutics, Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs MiMedx Group, Inc.